Össur hf. provided earnings guidance for the year 2024. The company's organic sales growth guidance is 5%-8%, expected to be driven by continued strong volume growth and moderate price increases.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.9 DKK | +3.10% | -2.61% | +8.93% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.93% | 1.83B | |
-9.29% | 21.33B | |
-6.92% | 16.56B | |
+6.61% | 13.49B | |
+8.45% | 10.01B | |
-13.54% | 2.16B | |
+41.82% | 1.71B | |
+12.09% | 583M | |
-.--% | 423M | |
+29.81% | 150M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur hf. Provides Earnings Guidance for the Year 2024